Optiscan Imaging Faces Revenue Decline, Focuses on Growth

Optiscan Imaging Limited (AU:OIL) has released an update.

Optiscan Imaging Limited reported a significant 31.2% drop in revenues and a 39.3% increase in losses for the financial year ending June 30, 2024, primarily due to decreased orders from key customer Carl Zeiss Meditec. Despite the decline in sales, the company raised $16.7 million through a capital offer to fund strategic expansion and reported an increase in net assets. They continue to invest heavily in R&D, leading to the unveiling of a new medical imaging device, InVue™, and expanding their US operations.

For further insights into AU:OIL stock, check out TipRanks’ Stock Analysis page.